Literature DB >> 9310016

Effect of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases.

M Tsuchida1, H Watanabe, T Watanabe, H Hirahara, M Haga, H Ohzeki, J Hayashi, H Miyamura, T Hirono, T Abo, S Eguchi.   

Abstract

Although recent studies have shown that adhesion molecules on alveolar macrophages are important in a variety of pulmonary diseases, there have been few studies on the phenotypic and functional changes of alveolar macrophages during cardiopulmonary bypass. To investigate the possible role of alveolar macrophages in activating pulmonary immunity during cardiopulmonary bypass, we measured the expression of adhesion molecules on alveolar macrophages and peripheral blood monocytes in patients undergoing cardiopulmonary bypass. Antigens were stained with monoclonal antibodies against adhesion molecules, and the expression of antigens was quantified by flow cytometry as the ratio of specific to nonspecific linear fluorescence. On alveolar macrophages obtained after the release of aortic cross-clamp, macrophages as compared with alveolar macrophages obtained before cardiopulmonary bypass, there was a significant enhancement of CD11a, CD11b, CD11c, and CD18. In addition, alveolar macrophages, but not peripheral monocytes, produced higher levels of TNF-alpha and IL-8 when they were cultured in vitro. A higher expression of CD11 and CD18 on alveolar macrophages and enhanced production of cytokines after release of the aortic cross-clamp may contribute to immune activation in lung by macrophage-lymphocyte interaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310016     DOI: 10.1164/ajrccm.156.3.9611055

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  1 in total

1.  Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass.

Authors:  Zhiwei Zhang; Yuan Wu; Yuan Zhao; Xianzhong Xiao; Junwen Liu; Xinmin Zhou
Journal:  Exp Ther Med       Date:  2013-03-22       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.